October 26, 2016

Miami-Dade Business Profile

Biscayne Pharmaceuticals

| 8/14/2013
Samuel Reich and Andrew Schally (sitting)
Samuel Reich (standing) and Andrew Schally

For more than half a century, Nobel Prize-winning scientist and University of Miami faculty member Andrew Schally has been researching the hormones that stimulate growth in the body’s tissues. Now his work is being used by Miami-based Biscayne Pharmaceuticals, which was founded last year and licensed from UM the rights to Schally’s inventions related to that research. The company, which Schally works with as scientific adviser, is using his discovery to develop possible treatments for cancer and heart disease.

Biscayne Pharma got going after a $1.5-million investment from its co-founders and Miami Beach investment firm Reich Group, whose Managing Partner Samuel Reich joined Biscayne Pharma as CEO. “This is a breakthrough that will really transform the way we treat cancer,” Reich says.

Tags: Miami-Dade, Healthcare, Technology/Innovation

Digital Access

Add digital to your current subscription, purchase a single digital issue, or start a new subscription to Florida Trend.

An overview of the features and articles in this month's issue of Florida Trend.


Florida Business News

Florida Trend Video Pick

A race to save the Key deer from grisly screwworm outbreak
A race to save the Key deer from grisly screwworm outbreak

In a Winn-Dixie strip mall just off the Overseas Highway, a storage room at the National Key Deer Refuge visitor center has become the first stop in an expanding campaign against a ghastly screwworm infecting the planet’s last herd.

Earlier Videos | Viewpoints@FloridaTrend

Ballot Box

Are you voting for - or against - Florida's Amendment 1, the "Rights of Electricity Consumers Regarding Solar Energy Choice"?

  • I am for it
  • I am against it

See Results

Ballot Box